Delivery Order SPE2D021DA002-SPE2D324F191L
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$1.6K
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a medication used to treat certain heart rhythm disorders. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award, valued at $1,605.15, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Procainamide Hydrochloride Injection USP, a pharmaceutical product, to support the medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a $1,605.15 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, issued under the DLA's SPE2DB program, is for the delivery of Procainamide Hydrochloride Injection USP, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is not associated with a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,605.15, is for the provision of Procainamide Hydrochloride Injection USP to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is valued at $5,470.89 and has an ultimate completion date of May 1, 2025. The contract was awarded by the Defense Logistics Agency (DLA) to provide procainamide hydrochloride, a pharmaceutical product, to support the medical supply needs of federal agencies. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a type of pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,277.81 contract is for the delivery of Procainamide Hydrochloride, a pharmaceutical product, with a completion date of December 13, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award, with ID SPE2D021DA002|SPE2D325F1756, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,210.30 firm fixed-price delivery order is for the provision of Procainamide Hydrochloride Injection USP, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a...
This federal contract award from the Defense Logistics Agency (DLA) was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,630.87 firm fixed-price delivery order is for the procurement of Procainamide HCL, a specialized medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,246.42, covers the procurement of Procainamide Hydrochloride, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS...